Bridging all oral DAA therapy from wait time to post‐liver transplant to improve HCV eradication?

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|1|1-4

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.1, 2015-01, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P143: Concordance between SVR4 and SVR24 in DAA Based Regimens: a real life experience including post‐liver transplant patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 91-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV‐decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 934-0874, Iss. 11, 2015-11 ,pp. : 1345-1349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV‐decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1345-1349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Participation in valued roles post-liver transplant

By Scott Patricia J  

The British Journal of Occupational Therapy, Vol. 73, Iss. 11, 2010-11 ,pp. : 517-523

College of Occupational Therapists

Access to resources Recommend Favorite

Editorial: the association of hepatitis C virus infection and post‐liver transplant diabetes

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 488-488

John Wiley & Sons Inc

Access to resources Recommend Favorite